LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 81.01 USD -1.33% Market Closed
Market Cap: 1.8B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one LMAT stock under the Base Case scenario is 69.3 USD. Compared to the current market price of 81.01 USD, LeMaitre Vascular Inc is Overvalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LMAT Relative Value
Base Case
69.3 USD
Overvaluation 14%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.1
P/S
P/S
Price to Sales
8.1
vs History
23
vs Industry
14
Median 3Y
7.4
Median 5Y
7
Industry
2.2
Forward
7.3
More Details
40.5
P/E
P/E
Price to Earnings
40.5
vs History
65
vs Industry
11
Median 3Y
48.3
Median 5Y
43.7
Industry
21.9
Forward
36.7
More Details
38.1
P/OCF
P/OCF
Price to OCF
38.1
vs History
42
vs Industry
7
Median 3Y
41.4
Median 5Y
35.4
Industry
14
More Details
44.5
P/FCFE
P/FCFE
Price to FCFE
44.5
vs History
46
vs Industry
34
Median 3Y
49.6
Median 5Y
44.1
Industry
19.7
More Details
5.3
P/B
P/B
Price to Book Value
5.3
vs History
33
vs Industry
13
Median 3Y
4.8
Median 5Y
4.5
Industry
2.1
More Details
7.5
EV/S
EV/S
Enterprise Value to Sales
7.5
vs History
31
vs Industry
15
Median 3Y
6.8
Median 5Y
6.6
Industry
2.3
Forward
6.8
More Details
10.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.9
vs History
39
vs Industry
17
Median 3Y
10.4
Median 5Y
10.1
Industry
4.8
More Details
27
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
27
vs History
34
vs Industry
10
Median 3Y
27.4
Median 5Y
24.7
Industry
11.5
Forward
22.9
More Details
32
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32
vs History
50
vs Industry
12
Median 3Y
33.8
Median 5Y
32.2
Industry
15.7
Forward
28.6
More Details
35.3
EV/OCF
EV/OCF
Enterprise Value to OCF
35.3
vs History
46
vs Industry
8
Median 3Y
38.1
Median 5Y
34.5
Industry
14
More Details
41.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
41.2
vs History
50
vs Industry
9
Median 3Y
46.3
Median 5Y
41.4
Industry
17.4
More Details
6.7
EV/IC
EV/IC
Enterprise Value to IC
6.7
vs History
20
vs Industry
11
Median 3Y
5.6
Median 5Y
4.7
Industry
1.8
More Details

Multiples Across Competitors

LMAT Competitors Multiples
LeMaitre Vascular Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
LeMaitre Vascular Inc
NASDAQ:LMAT
1.8B USD 8.1 40.5 27 32
US
Abbott Laboratories
NYSE:ABT
229.1B USD 5.4 17 22 31.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.5B USD 21.1 74.1 59.7 72.6
US
Boston Scientific Corp
NYSE:BSX
150.5B USD 8.6 74 35 48.6
US
Stryker Corp
NYSE:SYK
142.7B USD 6.1 49.9 24.7 29.8
IE
Medtronic PLC
NYSE:MDT
110.5B USD 3.3 23.7 13.3 18.9
DE
Siemens Healthineers AG
XETRA:SHL
50.9B EUR 2.2 24.4 13.7 19
US
Becton Dickinson and Co
NYSE:BDX
48.7B USD 2.3 32.1 12.9 24.1
US
Edwards Lifesciences Corp
NYSE:EW
43.1B USD 7.8 10.3 23.5 25.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42B USD 10.7 47 33.3 37.2
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
281.3B CNY 7.9 25.3 22.1 22.1

See Also

Summary
LMAT intrinsic value, competitors valuation, and company profile.
DCF Valuation
LMAT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LMAT stock valuation using valuation multiples.
Wall Street Estimates
LMAT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LMAT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 262,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.